P27KIP1 expression in gastric cancer: Differential pathways in the histological subtypes associated with Helicobacter pylori infection

Scandinavian Journal of Gastroenterology

Volumn 45, Issue 4, 2010, Pages 409-420

  Alves, Markěnia Kélia Santos ^a   Lima, Valeska Portela ^a   Ǎndré, Ngela Rosa ^a   Ferreira, Mrcia Valéria Pitombeira ^a   Barros, Marcos Aurélio Pessoa ^a   Rabenhorst, Silvia Helena Barem ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

C MYC; Gastric cancer; Helicobacter pylori genotypes; Histological subtypes; P27KIP1

Indexed keywords

BACTERIAL PROTEIN; CAGA PROTEIN; CAGE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MYC PROTEIN; UNCLASSIFIED DRUG; VACUOLATING TOXIN; VIRB PROTEIN; VIRB11 PROTEIN; BACTERIAL ANTIGEN; CAGA PROTEIN, HELICOBACTER PYLORI; CDKN1B PROTEIN, HUMAN; PICB PROTEIN, HELICOBACTER PYLORI; SIGNAL PEPTIDE; VACA PROTEIN, HELICOBACTER PYLORI;

ADULT; AGED; ARTICLE; BACTERIAL STRAIN; CANCER CLASSIFICATION; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; ADENOCARCINOMA; AGAR GEL ELECTROPHORESIS; CHI SQUARE DISTRIBUTION; ENZYME IMMUNOASSAY; GASTRECTOMY; GENETICS; MIDDLE AGED; PATHOGENICITY; STOMACH TUMOR;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CHI-SQUARE DISTRIBUTION; ELECTROPHORESIS, AGAR GEL; FEMALE; GASTRECTOMY; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOENZYME TECHNIQUES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS;

EID: 77949908207     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365520903521566     Document Type: Article

References (65)

1. BRASIL. Ministério da Saúde. Instituto Nacional do Câncer. Coordenação de Prevenção e Vigilância. Estimativas 2008: Incidência de Câncer no Brasil. Rio de Janeiro: INCA; 2008.
2. Konturek PC, Konturek SJ, Brzozowski T. Gastric cancer and Helicobacter pylori infection. J Physiol Pharmacol 2006;57:51-65.
3. Laurèn P. Two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 1965;64:31-49.
4. Smith MG, Hold GL, Tahara E, El-Omar EM. Cellular and molecular aspects of gastric cancer. World J Gastroenterol 2006;12:2979-2990
5. Correa P, Schneider BG. Etiology of gastric cancer: what is new? Cancer Epidemiol Biomarkers Prev 2005;14:1865-1868
6. Tahara E. Genetic pathways of two types of gastric cancer. IARC Sci Publ 2004;157:327-349
7. Peek RM Jr, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002;2:28-37.
8. IARC. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994;61:1-241.
9. Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. J Clin Invest 2004;113:321-333
10. Figueiredo C, Machado JC, Pharoah PM, Seruca R, Sousa S, Carvalho R, et al. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002;94:1680-1687
11. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002;347:1175-1186
12. Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R. Helicobacter pylori virulence and genetic geography. Science 1999;284:1328-1333
13. Jafari F, Shokrzadeh L, Dabiri H, Baghaei K, Yamaoka Y, Zojaji H, et al. Vaca genotypes of Helicobacter pylori in relation to cagA status and clinical outcomes in Iranian populations. Jpn J Infect Dis 2008;61:290-293
14. Atherton JC. The pathogenesis of Helicobacter pyloriinduced gastro-duodenal diseases. Annu Rev Pathol 2006;1:63-96.
15. Sozzi M, Tomasini ML, Vindigni C, Zanussi S, Tedeschi R, Basaglia G, et al. Heterogeneity of cag genotypes and clinical outcome of Helicobacter pylori infection. J Lab Clin Med 2005;146:262-270
16. Lu H, Yamaoka Y, Graham DY. Helicobacter pylori virulence factors: facts and fantasies. Curr Opin Gastroenterol 2005;21:653-659
17. Castillo-Rojas G, Mazarí-Hiriart M, López-Vidal Y. Helicobacter pylori: focus on CagA and VacA major virulence factors. Salud Publica Mex 2004;46:538-548
18. Wen S, Moss SF. Helicobacter pylori virulence factors in gastric carcinogenesis. Cancer Lett 2009;282:1-8.
19. Atherton JC, Cao P, Peek RM Jr, Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995;270:17771-17777
20. Wang HT, Li ZH, Yuan JP, Zhao W, Shi XD, Tong SQ, et al. Effect of Helicobacter pylori VacA on gene expression of gastric cancer cells. World J Gastroenterol 2005;11: 109-113
21. Zambon CF, Navaglia F, Basso D, Rugge M, Plebani M. Helicobacter pylori babA2, cagA, and s1 vacA genes work synergistically in causing intestinal metaplasia. J Clin Pathol 2003;56:287-291
22. Backert S, Müller EC, Jungblut PR, Meyer TF. Tyrosine phosphorylation patterns and size modification of the Helicobacter pylori CagA protein after translocation into gastric epithelial cells. Proteomics 2001;1:608-617
23. Krause S, Pansegrau W, Lurz R, de la Cruz F, Lanka E. Enzymology of type IV macromolecule secretion systems: the conjugative transfer regions of plasmids RP4 and R388 and the cag pathogenicity island of Helicobacter pylori encode structurally and functionally related nucleoside triphosphate hydrolases. J Bacteriol 2000;182:2761-2770
24. Maeda S, Yoshida H, Ikenoue T, Ogura K, Kanai F, Kato N, et al. Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates. Gut 1999;44:336-341
25. Akopyants NS, Clifton SW, Kersulyte D, Crabtree JE, Youree BE, Reece CA, et al. Analyses of the cag pathogenicity island of Helicobacter pylori. Mol Microbiol 1998;28:37-53.
26. Gamboa-Dominguez A, Seidl S, Reyes-Gutierrez E, Hermannstädter C, Quintanilla-Martinez L, Busch R, et al. Prognostic significance of p21WAF1/CIP1, p27Kip1, p53 and E-cadherin expression in gastric cancer. J Clin Pathol 2007;60:756-761
27. Kim SS, Meitner P, Konkin TA, Cho YS, Resnick MB, Moss SF. Altered expression of Skp2, c-Myc and p27 proteins but not mRNA after H. pylori eradication in chronic gastritis. Mod Pathol 2006;19:49-58.
28. Al-Moundhri MS, Nirmala V, Al-Hadabi I, Al-Mawaly K, Burney I, Al-Nabhani M, et al. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients. J Surg Oncol 2005;91:243-252
29. Shirin H, Hibshoosh H, Kawabata Y, Weinstein IB, Moss SF. p16Ink4a is overexpressed in H. pylori-associated gastritis and is correlated with increased epithelial apoptosis. Helicobacter 2003;8:66-71.
30. Ozturk Y, Ozer E, Lebe B, Bekem O, Buyukgebiz B. Immunohistochemical evaluation of p53 expression and proliferative activity in children with Helicobacter pylori associated gastritis. J Pediatr Gastroenterol Nutr 2005;40:467-470
31. Shibata A, Parsonnet J, Longacre TA, Garcia MI, Puligandla B, Davis RE, et al. CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma. Carcinogenesis 2002;23:419-424
32. Oda T, Murakami K, Nishizono A, Kodama M, Nasu M, Fujioka T. Long-term Helicobacter pylori infection in Japanese monkeys induces atrophic gastritis and accumulation of mutations in the p53 tumor suppressor gene. Helicobacter 2002;7:143-151
33. Alkarain A, Slingerland J. Deregulation of p27 by oncogenic signaling and its prognostic significance in breast cancer. Breast Cancer Res 2004;6:13-21.
34. Blain SW, Scher HI, Cordon-Cardo C, Koff A. p27 as a target for cancer therapeutics. Cancer Cell 2003;3:111-115
35. Chetty R. p27 protein and cancers of the gastrointestinal tract and liver: an overview. J Clin Gastroenterol 2003;37:23-27
36. Hengst L, Dulic V, Slingerland JM, Lees E, Reed SI. A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc Natl Acad Sci U S A 1994;91:5291-5295
37. McAllister SS, Becker-Hapak M, Pintucci G, Pagano M, Dowdy SF. Novel p27(kip1) C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions. Mol Cell Biol 2003;23:216-228
38. Philipp-Staheli J, Payne SR, Kemp CJ. p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer. Exp Cell Res 2001;264:148-168
39. Eguchi H, Herschenhous N, Kuzushita N, Moss SF. Helicobacter pylori increases proteasome-mediated degradation of p27(kip1) in gastric epithelial cells. Cancer Res 2003;63:4739-4746
40. Yang W, Shen J, Wu M, Arsura M, FitzGerald M, Suldan Z, et al. Repression of transcription of the p27(Kip1) cyclindependent kinase inhibitor gene by c-Myc. Oncogene 2001;20:1688-1702
41. Berns K, Martins C, Dannenberg JH, Berns A, Riele H, Bernards R. p27kip1-independent cell cycle regulation by MYC. Oncogene 2000;19:4822-4827
42. Perez-Roger I, Kim SH, Griffiths B, Sewing A, Land H. Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1). EMBO J 1999;18:5310-5320
43. Lee KH, Lee HE, Cho SJ, Cho YJ, Lee HS, Kim JH, et al. Immunohistochemical analysis of cell cycle-related molecules in gastric carcinoma: prognostic significance, correlation with clinicopathological parameters, proliferation and apoptosis. Pathobiology 2008;75:364-372
44. Yu J, Leung WK, Ng EK, To KF, Ebert MP, Go MY, et al. Effect of Helicobacter pylori eradication on expression of cyclin D2 and p27 in gastric intestinal metaplasia. Aliment Pharmacol Ther 2001;15:1505-1511
45. Shirin H, Sordillo EM, Kolevska TK, Hibshoosh H, Kawabata Y, Oh SH, et al. Chronic Helicobacter pylori infection induces an apoptosis-resistant phenotype associated with decreased expression of p27(kip1). Infect Immun 2000;68:5321-5328
46. Foster G, Twell D. Plant gene isolation principles and practice. Chichester, UK: Wiley; 1996. p. 426.
47. Lage AP, Godfroid E, Fauconnier A, Burette A, Butzler JP, Bollen A, et al. Diagnosis of Helicobacter pylori infection by PCR: comparison with other invasive techniques and detection of cagA gene in gastric biopsy specimens. J Clin Microbiol 1995;33:2752-2756
48. Domingo D, Alarcon T, Pietro N, Sanchez I, Lopez-Brea M. Caga and Vaca status of Spanish Helicobacter pylori clinical isolates. J Clin Microbiol 1999;37:2113-2114
49. Hsu SM, Raine L. Protein A, avidin, and biotin in immunohistochemistry. J Histochem Cytochem 1981;29: 1349-1353
50. Landberg G, Roos G. Proliferating cell nuclear antigen and Ki-67 antigen expression in human haematopoietic cells during growth stimulation and differentiation. Cell Prolif 1993;26:427-437
51. Kuzushita N, Rogers AB, Monti NA, Whary MT, Park MJ, Aswad BI, et al. p27KIP1 deficiency confers susceptibility to gastric carcinogenesis in Helicobacter pylori-infected mice. Gastroenterology 2005;129:1544-1556
52. Kamali-Sarvestani E, Bazargani A, Masoudian M, Lankarani K, Taghavi AR, Saberifiroozi M. Association of H. pylori cagA and vacA genotypes and IL-8 gene polymorphisms with clinical outcome of infection in Iranian patients with gastrointestinal diseases. World J Gastroenterol 2006;12:5205-5210
53. Lin HJ, Perng CL, Lo WC,Wu CW, Tseng GY, Li AF, et al. Helicobacter pylori cagA, iceA and vacA genotypes in patients with gastric cancer in Taiwan. World J Gastroenterol 2004;10:2493-2497
54. Björkholm B, Falk P, Engstrand L, Nyrén O. Helicobacter pylori: resurrection of the cancer link. J Intern Med 2003;253:102-119
55. Wiksten JP, Lundin J, Nordling S, Kokkola A, Boguslawski K, Haglund C. The prognostic value of p27 in gastric cancer. Oncology 2002;63:180-184
56. Sgambato A, Migaldi M, Leocata P, Ventura L, Criscuolo M, Di Giacomo C, et al. Loss of p27Kip1 expression is a strong independent prognostic factor of reduced survival in N0 gastric carcinomas. Cancer 2000;89:2247-2257
57. Saragoni L, Morgagni P, De Manzoni G, Tomezzoli A, Roviello F, Marrelli D, et al. Expression of p27 and proliferative (MIB-1), mitotic (MI) and apoptotic indices in early-phase (EGF) gastric carcinoma. Results of a study by the Italian Gastric Cancer Research Group (IRGGC). Pathologica 2003;95:22-30.
58. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-789
59. Zhang GX, Gu YH, Zhao ZQ, Xu SF, Zhang HJ, Wang HD, et al. Coordinate increase of telomerase activity and c-Myc expression in Helicobacter pylori-associated gastric diseases. World J Gastroenterol 2004;10:1759-1762
60. Bouchard C, Thieke K, Maier A, Saffrich R, Hanley-Hyde J, Ansorge W, et al. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27. EMBO J 1999;18:5321-5333
61. Lutz W, Leon J, Eilers M. Contributions of Myc to tumorigenesis. Biochim Biophys Acta 2002;1602:61-71.
62. Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor MK, Han K, et al. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 2002;8:1153-1160
63. Wu M, Bellas RE, Shen J, Yang W, Sonenshein GE. Increased p27Kip1 cyclin-dependent kinase inhibitor gene expression following anti-IgM treatment promotes apoptosis of WEHI 231 B cells. J Immunol 1999;163: 6530-6535
64. Kim JH, Kim HP, Jung CH, Hong MH, Hong MC, Bae HS, et al. Inhibition of cell cycle progression via p27KIP1 upregulation and apoptosis induction by an ethanol extract of Rhus verniciflua Stokes in AGS gastric cancer cells. Int J Mol Med 2006;18:201-208
65. Davison EA, Lee CS, Naylor MJ, Oakes SR, Sutherland RL, Hennighausen L, et al. The cyclin-dependent kinase inhibitor p27 (Kip1) regulates both DNA synthesis and apoptosis in mammary epithelium but is not required for its functional development during pregnancy. Mol Endocrinol 2003;17: 2436-2447